MA, Y., S, K., HHA, Ç., Hİ, B., S, Ç., H, O., . . . İ, E. (2026). Pathogenic Significance of Serum Syndecan-1 and Syndecan-4 in Psoriasis. Cutis, 117(1), 22. https://doi.org/10.12788/cutis.1323
Chicago Style (17th ed.) CitationMA, Yıldırım, Korkmaz S, Çelik HHA, Büyükbayram Hİ, Çelik S, Orhan H, Yıldırım M, and Erturan İ. "Pathogenic Significance of Serum Syndecan-1 and Syndecan-4 in Psoriasis." Cutis 117, no. 1 (2026): 22. https://doi.org/10.12788/cutis.1323.
MLA (9th ed.) CitationMA, Yıldırım, et al. "Pathogenic Significance of Serum Syndecan-1 and Syndecan-4 in Psoriasis." Cutis, vol. 117, no. 1, 2026, p. 22, https://doi.org/10.12788/cutis.1323.
Warning: These citations may not always be 100% accurate.